This contract expires in 264 days (Feb 28, 2027).
QUANTITATIVE BIOSCIENCES, INC. - CELL AND GENE THERAPY PROCESS ANALYTICAL TECHNOLOGY AND QUALITY CONTROL TESTING
Key Details
Description
CELL AND GENE THERAPY PROCESS ANALYTICAL TECHNOLOGY AND QUALITY CONTROL TESTING
Context & Analysis
On Feb 26, 2026, Department of the Interior obligated $600,000 to QUANTITATIVE BIOSCIENCES, INC. for cell and gene therapy process analytical technology and quality control testing. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition after exclusion of sources with 2 offers received. The procurement used a SMALL BUSINESS SET ASIDE - TOTAL set-aside. Performance is located in SAN DIEGO, CA. The contract is scheduled through Feb 28, 2027 — approximately 9 months remaining. This award is one of several similar procurements from Department of the Interior under NAICS 541714 — related awards are listed below.
Contractor Information
Similar Awards
VASCULAR ENGINEERED INTERNAL NETWORK THE OBJECTIVE OF THIS CONTRACT IS TO PROLONG THE SERVICEABILITY OF DOD STRUCTURES AND AIRFIELD PAVEMENTS BY DEVELOPING A REPARATIVE VASCULATURE FOR CONCRETE CONSISTING OF A FIBROUS VASCULAR STRUCTURE DECORATED WI
BATTELLE MEMORIAL INSTITUTE
$7.6M
PHYSICAL SCIENCES INC. (PSI) AIMS TO DEVELOP AND COMMERCIALIZE A FIRST-OF-ITS-KIND IN-LINE CYTOMETRY PROCESS ANALYTICAL TECHNOLOGY (ILC-PAT) THAT ENABLES REAL-TIME, SINGLE-CELL LEVEL MONITORING OF CRITICAL BIOPROCESS PARAMETERS TO IMPROVE THE MANUFAC
PHYSICAL SCIENCES INC.
$3.5M
PHYSICAL SCIENCES INC. (PSI) AIMS TO DEVELOP AND COMMERCIALIZE A FIRST-OF-ITS-KIND IN-LINE CYTOMETRY PROCESS ANALYTICAL TECHNOLOGY (ILC-PAT) THAT ENABLES REAL-TIME, SINGLE-CELL LEVEL MONITORING OF CRITICAL BIOPROCESS PARAMETERS TO IMPROVE THE MANUFAC
PHYSICAL SCIENCES INC.
$3.5M
LEVERAGING IKRAPH FOR PERSONALIZED NUTRITION PLANNING IN CANCER PREVENTION AND MANAGEMENT
INSILICOM LLC
$600,000
CELL AND GENE THERAPY PROCESS ANALYTICAL TECHNOLOGY AND QUALITY CONTROL TESTING
HELIOWAVE TECHNOLOGIES INC
$600,000
Stay Updated
Get notified about new opportunities matching your interests.